Arvinas (ARVN) News Today $6.64 +0.11 (+1.68%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARVN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 20 at 9:00 AM | prnewswire.comNorthern Trust Corp Purchases 42,638 Shares of Arvinas, Inc. (NASDAQ:ARVN)Northern Trust Corp boosted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 631,131 shares of the company's stock after buyingMay 19 at 3:17 AM | marketbeat.comArvinas Inc.May 18 at 6:59 PM | marketwatch.comRTW Investments LP Grows Stake in Arvinas, Inc. (NASDAQ:ARVN)RTW Investments LP boosted its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 19.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,334,308 shares of the company's stock after purchasing an addiMay 18 at 6:54 AM | marketbeat.comUBS Group Cuts Arvinas (NASDAQ:ARVN) Price Target to $21.00May 18 at 1:23 AM | americanbankingnews.comPatient Square Capital LP Makes New $1.66 Million Investment in Arvinas, Inc. (NASDAQ:ARVN)Patient Square Capital LP acquired a new position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 86,627 shares of the company's stock, valued at approximately $1,661,000. Arvinas mMay 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 13, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. ...May 12, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 12, 2025 | prnewswire.comMorgan Stanley Cuts Arvinas (NASDAQ:ARVN) Price Target to $11.00May 12, 2025 | americanbankingnews.comDimensional Fund Advisors LP Raises Position in Arvinas, Inc. (NASDAQ:ARVN)Dimensional Fund Advisors LP boosted its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 28.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 843,430 shares of the company's stock after purchasing aMay 11, 2025 | marketbeat.comFY2025 EPS Estimates for Arvinas Raised by Cantor FitzgeraldArvinas, Inc. (NASDAQ:ARVN - Free Report) - Stock analysts at Cantor Fitzgerald raised their FY2025 EPS estimates for Arvinas in a research report issued to clients and investors on Tuesday, May 6th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings of ($0.56) peMay 10, 2025 | marketbeat.comAlgert Global LLC Has $3.95 Million Stake in Arvinas, Inc. (NASDAQ:ARVN)Algert Global LLC lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 22.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 205,988 shares of the company's stock after acquiring an additional 37,927May 9, 2025 | marketbeat.comCitigroup Cuts Arvinas (NASDAQ:ARVN) Price Target to $9.50Citigroup lowered their target price on shares of Arvinas from $10.00 to $9.50 and set a "neutral" rating for the company in a research note on Monday.May 7, 2025 | marketbeat.comBMO Capital Markets Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock PriceBMO Capital Markets dropped their price target on Arvinas from $20.00 to $10.00 and set an "outperform" rating on the stock in a research note on Monday.May 7, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Given "Hold" Rating at Truist FinancialTruist Financial restated a "hold" rating and issued a $11.00 target price on shares of Arvinas in a report on Monday.May 7, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), Design Therapeutics (DSGN) and Arvinas Holding Company (ARVN)May 6, 2025 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. ...May 6, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 6, 2025 | prnewswire.comTruist Securities Downgrades Arvinas (ARVN)May 6, 2025 | msn.comArvinas Holding Company (ARVN) Receives a Hold from WedbushMay 6, 2025 | theglobeandmail.comKirby McInerney LLP Announces Investigation of Potential Claims Against Arvinas, Inc. (ARVN) on Behalf of InvestorsMay 5, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNMay 5, 2025 | globenewswire.comArvinas, Inc. (NASDAQ:ARVN) Short Interest Up 21.0% in AprilArvinas, Inc. (NASDAQ:ARVN - Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 7,730,000 shares, a growth of 21.0% from the March 31st total of 6,390,000 shares. Based on an average trading volume of 2,260,000 shares, the days-to-cover ratio is currently 3.4 days. Currently, 11.9% of the shares of the company are sold short.May 5, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Posts Quarterly Earnings Results, Beats Estimates By $2.07 EPSArvinas (NASDAQ:ARVN - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.93) by $2.07. Arvinas had a negative return on equity of 33.75% and a negative net margin of 75.51%. The business's revenue was up 646.2% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.97) EPS.May 5, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Shares Bought by ArrowMark Colorado Holdings LLCArrowMark Colorado Holdings LLC grew its position in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 42.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,776,555 shares of the company's stock after buying an additional 532,105 shaMay 5, 2025 | marketbeat.comArvinas: Yet Another Biotech Trading Below Net Cash, But It's Only A Mild Bull CaseMay 4, 2025 | seekingalpha.comArvinas, Inc. Just Reported A Surprise Profit And Analysts Updated Their EstimatesMay 4, 2025 | finance.yahoo.comPiper Sandler Reiterates Overweight Rating for Arvinas (NASDAQ:ARVN)Piper Sandler reiterated an "overweight" rating and set a $14.00 price objective (down previously from $24.00) on shares of Arvinas in a research report on Friday.May 4, 2025 | marketbeat.comHC Wainwright Has Lowered Expectations for Arvinas (NASDAQ:ARVN) Stock PriceHC Wainwright reduced their price objective on shares of Arvinas from $81.00 to $24.00 and set a "buy" rating for the company in a research note on Friday.May 4, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Price Target Cut to $16.00 by Analysts at BarclaysBarclays lowered their price objective on shares of Arvinas from $32.00 to $16.00 and set an "overweight" rating on the stock in a research report on Friday.May 4, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Lowered to Hold Rating by TD CowenTD Cowen lowered Arvinas from a "buy" rating to a "hold" rating in a research report on Friday.May 4, 2025 | marketbeat.comJefferies Financial Group Reaffirms "Hold" Rating for Arvinas (NASDAQ:ARVN)Jefferies Financial Group reiterated a "hold" rating and issued a $10.00 price target (down from $52.00) on shares of Arvinas in a research note on Friday.May 4, 2025 | marketbeat.comBoxer Capital Management LLC Makes New Investment in Arvinas, Inc. (NASDAQ:ARVN)Boxer Capital Management LLC purchased a new stake in Arvinas, Inc. (NASDAQ:ARVN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,058,614 shares of the company's stock, valued at apMay 4, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Has $12.58 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN)Schonfeld Strategic Advisors LLC grew its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 84.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 656,100 shares of the company's stock after purchasing anMay 3, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) have received an average recommendation of "Moderate Buy" from the sixteen ratings firms that are covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and eleven have issued a buy recomMay 3, 2025 | marketbeat.comJefferies Downgrades Arvinas (ARVN)May 2, 2025 | msn.comArvinas Shares Drop; Cancels Two Drug Trials With Pfizer Amid Capital Markets ChallengesMay 2, 2025 | marketwatch.comArvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...May 2, 2025 | finance.yahoo.comHere are 1 Main Capital Partners’ Views on Arvinas (ARVN)May 2, 2025 | finance.yahoo.comArvinas, Inc. (ARVN) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comBREAKING: Block & Leviton Investigating Arvinas, Inc. (ARVN) For Securities Fraud After Shares Fall Over 20%; Investors Encouraged to Contact the Firm to Potentially Recover LossesMay 1, 2025 | globenewswire.comArvinas stock tumbles following workforce reduction and trial removalsMay 1, 2025 | investing.comArvinas stock slides after eliminating trials, reducing workforceMay 1, 2025 | msn.comArvinas (ARVN) to Release Quarterly Earnings on TuesdayArvinas (NASDAQ:ARVN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-arvinas-inc-stock/)May 1, 2025 | marketbeat.comArvinas Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 1, 2025 | globenewswire.comArvinas Q1 2025 Earnings PreviewApril 30, 2025 | msn.comPrice T Rowe Associates Inc. MD Boosts Holdings in Arvinas, Inc. (NASDAQ:ARVN)Price T Rowe Associates Inc. MD lifted its holdings in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,103,011 shares of the company's stockApril 30, 2025 | marketbeat.comBarclays PLC Boosts Stake in Arvinas, Inc. (NASDAQ:ARVN)Barclays PLC raised its position in Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 43.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 175,019 shares of the company's stock after buying an additional 53,320 shares during the period. Barclays PApril 30, 2025 | marketbeat.comRenaissance Technologies LLC Has $1.32 Million Stake in Arvinas, Inc. (NASDAQ:ARVN)Renaissance Technologies LLC reduced its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 52.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 68,900 shares of the company's stock after selling 75,500 shares durApril 30, 2025 | marketbeat.com Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address ARVN Media Mentions By Week ARVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARVN News Sentiment▼0.200.65▲Average Medical News Sentiment ARVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARVN Articles This Week▼76▲ARVN Articles Average Week Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CGON News Today TARS News Today GLPG News Today APGE News Today RXRX News Today TWST News Today BEAM News Today ARQT News Today AGIO News Today SDGR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARVN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arvinas With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARVN Stock Free ARVN Stock Alerts